Glaucoma Awareness

iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject

The pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the US, has received positive feedback from glaucoma surgeons involved in the trial.

Survey from Bausch + Lomb, Glaucoma Research Foundation reveals emotional, social impacts of hyperemia on glaucoma patients

Marking Glaucoma Awareness Month this month, Bausch + Lomb and the Glaucoma Research Foundation have released key findings from a survey of glaucoma patients that was designed to gain a greater understanding of the impact that hyperemia can have in the treatment and lives of people living with glaucoma.

Surgery developed by ophthalmologist at Dean McGee Eye Institute proves its effectiveness

Mahmoud A. Khaimi, MD, developed a minimally invasive glaucoma surgery known as ab-interno canaloplasty as a treatment option between topical therapies and invasive surgery. The technique continues to prove its value.